145 related articles for article (PubMed ID: 32131407)
1. PGE
Nava S; Lisini D; Frigerio S; Pogliani S; Pellegatta S; Gatti L; Finocchiaro G; Bersano A; Parati EA
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131407
[TBL] [Abstract][Full Text] [Related]
2. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
[TBL] [Abstract][Full Text] [Related]
3. Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.
Salem ML; Nassef M; Gomaa S; Essa I
Biomed Pharmacother; 2017 Sep; 93():286-295. PubMed ID: 28648976
[TBL] [Abstract][Full Text] [Related]
4. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
5. An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.
Nava S; Dossena M; Pogliani S; Pellegatta S; Antozzi C; Baggi F; Gellera C; Pollo B; Parati EA; Finocchiaro G; Frigerio S
PLoS One; 2012; 7(12):e52301. PubMed ID: 23284979
[TBL] [Abstract][Full Text] [Related]
6. A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.
Jarnjak-Jankovic S; Hammerstad H; Saebøe-Larssen S; Kvalheim G; Gaudernack G
BMC Cancer; 2007 Jul; 7():119. PubMed ID: 17608923
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
Dobrovolskienė N; Pašukonienė V; Darinskas A; Kraśko JA; Žilionytė K; Mlynska A; Gudlevičienė Ž; Mišeikytė-Kaubrienė E; Schijns V; Lubitz W; Kudela P; Strioga M
Vaccine; 2018 Jul; 36(29):4171-4180. PubMed ID: 29895501
[TBL] [Abstract][Full Text] [Related]
8. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
Ponsaerts P; Van den Bosch G; Cools N; Van Driessche A; Nijs G; Lenjou M; Lardon F; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunol; 2002 Aug; 169(4):1669-75. PubMed ID: 12165485
[TBL] [Abstract][Full Text] [Related]
9. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
[TBL] [Abstract][Full Text] [Related]
10. Fast monocyte-derived dendritic cell-based immunotherapy.
Ramadan G
Methods Mol Biol; 2014; 1139():131-44. PubMed ID: 24619676
[TBL] [Abstract][Full Text] [Related]
11. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
12. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
13. Fast generation of dendritic cells.
Kvistborg P; Boegh M; Pedersen AW; Claesson MH; Zocca MB
Cell Immunol; 2009; 260(1):56-62. PubMed ID: 19818956
[TBL] [Abstract][Full Text] [Related]
14. Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells.
De Vleeschouwer S; Spencer Lopes I; Ceuppens JL; Van Gool SW
J Neurooncol; 2007 Sep; 84(2):131-40. PubMed ID: 17361330
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandin E2, lipopolysaccharide, IFN-gamma and cytokines on the generation and function of fast-DC.
Alldawi L; Takahashi M; Narita M; Ayres F; Tsukada N; Osman Y; Furukawa T; Aizawa Y
Cytotherapy; 2005; 7(2):195-202. PubMed ID: 16040399
[TBL] [Abstract][Full Text] [Related]
16. Clinical-scale generation of dendritic cells in a closed system.
Sorg RV; Ozcan Z; Brefort T; Fischer J; Ackermann R; Müller M; Wernet P
J Immunother; 2003; 26(4):374-83. PubMed ID: 12843800
[TBL] [Abstract][Full Text] [Related]
17. Poly Lactic-co-Glycolic Acid Nanoparticles Containing Human Gastric Tumor Lysates as Antigen Delivery Vehicles for Dendritic Cell-Based Antitumor Immunotherapy.
Kohnepoushi C; Nejati V; Delirezh N; Biparva P
Immunol Invest; 2019 Nov; 48(8):794-808. PubMed ID: 31094258
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
[TBL] [Abstract][Full Text] [Related]
19. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
[TBL] [Abstract][Full Text] [Related]
20. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]